The drug effects questionnaire: psychometric support across three drug types

被引:181
|
作者
Morean, Meghan E. [1 ]
de Wit, Harriet [2 ]
King, Andrea C. [2 ]
Sofuoglu, Mehmet [1 ]
Rueger, Sandra Y. [2 ,3 ]
O'Malley, Stephanie S. [1 ]
机构
[1] Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat, New Haven, CT 06519 USA
[2] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL USA
[3] Wheaton Coll, Billy Graham Ctr, Dept Psychol, Wheaton, IL 60187 USA
关键词
Amphetamine; Alcohol; Nicotine; Drug; ABUSE LIABILITY; ALCOHOL; AMPHETAMINE; ALPRAZOLAM; NALTREXONE; INCREASES; RESPONSES; HEROIN; LIGHT; MOOD;
D O I
10.1007/s00213-012-2954-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The Drug Effects Questionnaire (DEQ) is widely used in studies of acute subjective response (SR) to a variety of substances, but the format of the DEQ varies widely across studies, and details of its psychometric properties are lacking. Thus, the field would benefit from demonstrating the reliability and validity of the DEQ for use across multiple substances. The current study evaluated the psychometric properties of several variations of DEQ items, which assessed the extent to which participants (1) feel any substance effect(s), (2) feel high, (3) like the effects, (4) dislike the effects, and (5) want more of the substance using 100-mm visual analog scales. DEQ data from three placebo-controlled studies were analyzed to examine SR to amphetamine, nicotine, and alcohol. We evaluated the internal structure of the DEQ for use with each substance as well as relationships between scale items, measures of similar constructs, and substance-related behaviors. Results provided preliminary psychometric support for items assessing each DEQ construct (feel, high, dislike, like, and more). Based on the study results, we identify several common limitations of extant variants of the DEQ and recommend an improved version of the measure. The simplicity and brevity of the DEQ combined with its promising psychometric properties support its use in future SR research across a variety of substances.
引用
收藏
页码:177 / 192
页数:16
相关论文
共 50 条
  • [41] DRUG DELIVERY New targets for drug delivery across the BBB
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (02) : 84 - 85
  • [42] Agents of support: psychometric properties of the Cancer Perceived Agents of Social Support (CPASS) questionnaire
    Goldzweig, Gil
    Hasson-Ohayon, Ilanit
    Meirovitz, Amichay
    Braun, Michal
    Hubert, Ayala
    Baider, Lea
    PSYCHO-ONCOLOGY, 2010, 19 (11) : 1179 - 1186
  • [43] Drug absorption: Getting it across
    Jack, DB
    DRUG NEWS & PERSPECTIVES, 1997, 10 (06) : 370 - 373
  • [44] Psychometric properties of the Three Factor Eating Questionnaire in healthcare personnel
    del Carmen Perez-Fuentes, Ma
    Molero Jurado, Ma del Mar
    Gazquez Linares, Jose Jesus
    Oropesa Ruiz, Nieves Fatima
    NUTRICION HOSPITALARIA, 2019, 36 (02) : 434 - 440
  • [45] Drug prices across the EU
    不详
    EJHP PRACTICE, 2011, 17 (04): : 10 - 10
  • [46] Drug delivery across the skin
    Touitou, E
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (07) : 723 - 733
  • [47] Drug Transport Across the Placenta
    Eshkoli, Tamar
    Sheiner, Eyal
    Ben-Zvi, Zvi
    Feinstein, Valeria
    Holcberg, Gershon
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (05) : 707 - 714
  • [48] PSYCHOMETRIC CHANGES ASSOCIATED WITH RESPONSE TO DRUG TREATMENT
    PHILIP, AE
    BRITISH JOURNAL OF SOCIAL AND CLINICAL PSYCHOLOGY, 1971, 10 (JUN): : 138 - &
  • [49] Monitoring "promiscuous" drug effects on single cells of multiple cell types
    Kuang, Y
    Walt, DR
    ANALYTICAL BIOCHEMISTRY, 2005, 345 (02) : 320 - 325
  • [50] Pivotal trial characteristics and types of endpoints used to support Food and Drug Administration rare disease drug approvals between 2013 and 2022
    Hong, Kyungwan
    Nugent, Bridget
    Bandukwala, Abbas
    Schuck, Robert
    Tomita, York
    Pepe, Salvatore
    Doi, Mary
    Winiecki, Scott
    Lee, Kerry Jo
    CLINICAL TRIALS, 2025,